Zhi-Chao Chen1, Jinghuan Gan1, Yaqi Yang2, Qingbo Meng2, Jiuyan Han1, Yong Ji1,3. 1. Department of Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 2. Tianjin Medical University, Tianjin, China. 3. Department of Neurology, Tianjin Key Laboratory of Cerebrovascular and of Neurodegenerative Diseases, Tianjin Dementia Institute, Tianjin Huanhu Hospital, Tianjin, China.
Abstract
BACKGROUND: The frequency of vascular risk factors (VRFs) and the relationship between vascular pathology and cognitive function in neurodegenerative disease remains incompletely understood. OBJECTIVE: The purpose of this study was to describe the frequency of VRFs and vascular pathology and explore the relationship between vascular pathology and cognitive function in dementia with Lewy bodies (DLB). METHODS: This study included 363 autopsy-confirmed DLB and 753 Alzheimer's disease (AD) patients from the National Alzheimer's Coordinating Center (NACC) database. We used chi-squared test and analysis of variance to compare the VRFs and related factors in DLB and AD. Multinomial logistic regression and Spearman's correlation test were used to examine the relationship between vascular pathology and cognitive function. RESULTS: No significant differences of VRFs were identified between DLB and AD. Alzheimer's disease patients had higher rates of microinfarcts (23.5% vs. 16.3%, p = 0.005) and moderate to severe amyloid angiopathy (45.9% vs. 36.1%, p = 0.002). In DLB patients, only cerebral amyloid angiopathy (CAA) pathology was negatively correlated with memory domain (r = -0.263, p < 0.001) and language (r = -0.112,p = 0.034). The rates of APOE ε4 allele carriers (60.0% vs. 44.9%, p = 0.004) and CAA pathology (45.9% vs.23.4%, p < 0.001) were much higher in the group with an intermediate likelihood of DLB than in the group with a high likelihood. There was a negative correlation between CAA pathology and memory (logical memory) in the group with an intermediate likelihood of DLB. CONCLUSION: No difference of VRFs was identified between autopsy-confirmed DLB and AD. Cerebral amyloid angiopathy was shown to be an important pathology in DLB, which specifically correlated with memory and language. The groups with high and intermediate likelihood of DLB differed in terms of CAA pathology, and CAA pathology may play an important role in the development of DLB.
BACKGROUND: The frequency of vascular risk factors (VRFs) and the relationship between vascular pathology and cognitive function in neurodegenerative disease remains incompletely understood. OBJECTIVE: The purpose of this study was to describe the frequency of VRFs and vascular pathology and explore the relationship between vascular pathology and cognitive function in dementia with Lewy bodies (DLB). METHODS: This study included 363 autopsy-confirmed DLB and 753 Alzheimer's disease (AD) patients from the National Alzheimer's Coordinating Center (NACC) database. We used chi-squared test and analysis of variance to compare the VRFs and related factors in DLB and AD. Multinomial logistic regression and Spearman's correlation test were used to examine the relationship between vascular pathology and cognitive function. RESULTS: No significant differences of VRFs were identified between DLB and AD. Alzheimer's disease patients had higher rates of microinfarcts (23.5% vs. 16.3%, p = 0.005) and moderate to severe amyloid angiopathy (45.9% vs. 36.1%, p = 0.002). In DLB patients, only cerebral amyloid angiopathy (CAA) pathology was negatively correlated with memory domain (r = -0.263, p < 0.001) and language (r = -0.112,p = 0.034). The rates of APOE ε4 allele carriers (60.0% vs. 44.9%, p = 0.004) and CAA pathology (45.9% vs.23.4%, p < 0.001) were much higher in the group with an intermediate likelihood of DLB than in the group with a high likelihood. There was a negative correlation between CAA pathology and memory (logical memory) in the group with an intermediate likelihood of DLB. CONCLUSION: No difference of VRFs was identified between autopsy-confirmed DLB and AD. Cerebral amyloid angiopathy was shown to be an important pathology in DLB, which specifically correlated with memory and language. The groups with high and intermediate likelihood of DLB differed in terms of CAA pathology, and CAA pathology may play an important role in the development of DLB.
Authors: Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Alzheimers Dement Date: 2016-08-10 Impact factor: 21.566
Authors: Kejal Kantarci; Tanis J Ferman; Bradley F Boeve; Stephen D Weigand; Scott Przybelski; Prashanthi Vemuri; Melissa E Murray; Melissa M Murray; Matthew L Senjem; Glenn E Smith; David S Knopman; Ronald C Petersen; Clifford R Jack; Joseph E Parisi; Dennis W Dickson Journal: Neurology Date: 2012-07-25 Impact factor: 9.910
Authors: Yujing Zhao; Dana L Tudorascu; Oscar L Lopez; Ann D Cohen; Chester A Mathis; Howard J Aizenstein; Julie C Price; Lewis H Kuller; M Ilyas Kamboh; Steven T DeKosky; William E Klunk; Beth E Snitz Journal: JAMA Neurol Date: 2018-01-01 Impact factor: 18.302
Authors: Nevicia F Case; Anna Charlton; Angela Zwiers; Saima Batool; Cheryl R McCreary; David B Hogan; Zahinoor Ismail; Charlotte Zerna; Shelagh B Coutts; Richard Frayne; Brad Goodyear; Angela Haffenden; Eric E Smith Journal: Stroke Date: 2016-06-23 Impact factor: 7.914
Authors: Anand Viswanathan; Pratik Patel; Rosanna Rahman; R N Kaveer Nandigam; Catherine Kinnecom; Luc Bracoud; Jonathan Rosand; Hugues Chabriat; Steven M Greenberg; Eric E Smith Journal: Stroke Date: 2008-04-24 Impact factor: 7.914
Authors: Sigurdur Sigurdsson; Thor Aspelund; Olafur Kjartansson; Elias F Gudmundsson; Maria K Jonsdottir; Gudny Eiriksdottir; Palmi V Jonsson; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer Journal: Stroke Date: 2017-08-01 Impact factor: 7.914
Authors: Arsenije Subotic; Cheryl R McCreary; Feryal Saad; Amanda Nguyen; Ana Alvarez-Veronesi; Angela M Zwiers; Anna Charlton; Andrew E Beaudin; Zahinoor Ismail; G Bruce Pike; Eric E Smith Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Emma E F Kleipool; Marijke C Trappenburg; Hannke F M Rhodius-Meester; Afina W Lemstra; Wiesje M van der Flier; Mike J L Peters; Majon Muller Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472